Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA

Paolini John F. exercised options for 5,831 Kiniksa Pharmaceuticals International, Plc shares (Form 4)

Traded Apr 1, 2026 · Filed Apr 3, 2026

On Apr 1, 2026, Paolini John F. (CHIEF MEDICAL OFFICER) exercised options for 5,831 Kiniksa Pharmaceuticals International, Plc shares, leaving 64,334 shares. Filed Apr 3, 2026 (Form 4).

Options exercised
5,831 shares
Holding after
64,334 shares
Trading plan
No
Role
CHIEF MEDICAL OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Class A Ordinary ShareOption exercise5,83167,155Direct
Apr 1, 2026Class A Ordinary ShareShares withheld for tax2,821US$48.1364,334Direct

Source

View original at SEC

Related